Clinical Trials
2 trialsNCT04617821 2022-01-28
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer
Fudan University
Phase 3 Unknown
NCT02717091 2020-09-10
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer
Nagoya University
Phase 2 Unknown